Comparative analysis of programmed cell death ligand 1 (PD-L1) assays in renal cell carcinoma

被引：0
|
作者：
Shim, B. [1 ]
Lee, K. S. [1 ]
Yun, S. [2 ]
Lee, K. [3 ]
Moon, S. [1 ]
Choe, G. [1 ,4 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea
[2] Samkwang Med Labs, Dept Diagnost Pathol, Seoul, South Korea
[3] Kangwon Natl Univ Hosp, Dept Pathol, Chuncheon Si, Gangwon Do, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-17-069
引用
收藏
页码：S185 / S185
页数：1
相关论文
共 50 条
  • [1] Comparative analysis of programmed cell death ligand 1 assays in renal cell carcinoma
    Lee, Kyu Sang
    Choe, Gheeyoung
    Yun, Sumi
    Lee, Kyoungyul
    Moon, Seyoung
    Lee, Sangchul
    Hong, Sung Kyu
    Byun, Seok-Soo
    Lee, Sang Eun
    [J]. HISTOPATHOLOGY, 2020, 77 (01) : 67 - 78
  • [2] Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC)
    Abbas, M.
    Steffens, S.
    Bellut, M.
    Eggers, H.
    Grosshennig, A.
    Becker, J. U.
    Wegener, G.
    Schrader, A. J.
    Gruenwald, V.
    Ivanyi, P.
    [J]. MEDICAL ONCOLOGY, 2016, 33 (07)
  • [3] Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC)
    M. Abbas
    S. Steffens
    M. Bellut
    H. Eggers
    A. Großhennig
    J. U. Becker
    G. Wegener
    A. J. Schrader
    V. Grünwald
    P. Ivanyi
    [J]. Medical Oncology, 2016, 33
  • [4] Clinicopathological and prognostic value of programmed death ligand-1 (PD-L1) in renal cell carcinoma: a meta-analysis
    Xu, Feng
    Xu, Lingling
    Wang, Qian
    An, Guangyu
    Feng, Guosheng
    Liu, Fuquan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 14595 - 14603
  • [5] Programmed Cell Death 1 Ligand 1 (PD-L1) Expression in Thymoma
    Yokoyama, Shintaro
    Miyoshi, Hiroaki
    Nishi, Tatsuya
    Matsumoto, Ryouichi
    Hashiguchi, Toshihiro
    Murakami, Daigo
    Kashihara, Masaki
    Takamori, Shinzo
    Akagi, Yoshito
    Ohshima, Koichi
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S503 - S503
  • [6] Programmed death ligand-1 (PD-L1) expression in penile squamous cell carcinoma
    Wang, Jennifer
    Rodriguez, Jaime
    Rao, Priya
    Pettaway, Curtis Alvin
    Pagliaro, Lance C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [7] Programmed-cell death ligand 1 (PD-L1) expression in equine sarcoids and squamous cell carcinoma
    Pimenta, Jose
    Prada, Justina
    Pires, Isabel
    Cotovio, Mario
    [J]. OPEN VETERINARY JOURNAL, 2024, 14 (06) : 1476 - 1482
  • [8] Prognostic value of programmed cell death ligand (PD-L1) for hepatocellular carcinoma: a meta-analysis
    Li, Xiao-Song
    Li, Jun-Wei
    Li, Hui
    Jiang, Tao
    [J]. BIOSCIENCE REPORTS, 2020, 40
  • [9] miRNA-A and programmed death ligand 1 (PD-L1) expression in oral squamous cell carcinoma
    Hyung, Hong
    Ko, Yoon Ho
    Jin, Lee Hee
    Jeon, Sang Hoon
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [10] Programmed death-ligand 1 (PD-L1) expression in small cell carcinoma of bladder.
    Sanguino, Angela
    Samiei, Arash
    Pasricha, Gurleen
    Harinath, Lakshmi
    Miller, Ralph
    Lyne, John
    Silverman, Jan F.
    Mao, Shifeng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345